Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05428514
Other study ID # 22-04-7182
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 30, 2022
Est. completion date December 1, 2025

Study information

Verified date May 2022
Source University of Notre Dame
Contact William Evans, PhD
Phone 5746317039
Email wevans1@nd.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Moms will call and agencies will determine if she is eligible based on basic criteria. If she is eligible, the agency will send her an intake application link to complete, which includes a consent form. After completing the survey, if she is still eligible, she will be placed on a waitlist for services. When a bed becomes available in an individual agency, the agency will call two moms at the top of the waitlist, conduct in-person interviews to confirm eligibility and good fit. They will use a computer to randomly assign one to treatment and one to control. Agency will let moms know of their status and will allow the treatment mom to move in. Moms in treatment and control will be surveyed approximately one year post the mother's reported due date of the child.


Description:

Read more »
Read more »

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Maternity Housing
Receives a bed in the maternity home, wrap-around services, etc.

Locations

Country Name City State
United States University of Notre Dame Notre Dame Indiana

Sponsors (6)

Lead Sponsor Collaborator
University of Notre Dame Aid for Women, Bethlehem House, In My Shoes, Maggie's Place, USA, Our Lady's Inn, USA

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in rates of self-reported taking baby to term between treatment and control groups The research team will use self-reported rates of taking the baby to term between treatment and control groups 1 year after approximate due date of baby
Primary Difference in rates of self-reported retaining custody of baby between treatment and control groups The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported retaining custody of the baby 1 year after approximate due date of baby
Primary Difference in rates of self-reported loneliness and depression between treatment and control groups The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported loneliness and depression levels. 1 year after approximate due date of baby
Primary Difference in rates of self-reported life satisfaction between treatment and control groups The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported life satisfaction 1 year after approximate due date of baby
Primary Difference in rates of self-reported sense of self-efficacy between treatment and control groups The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported sense of self-efficacy 1 year after approximate due date of baby
Primary Difference in housing stability between treatment and control groups The research team will use self-reported independent living status and whether the mom has a mortgage or lease in her own name at the time of follow to quantify the impact of receiving a bed in the maternity home on housing stability. 1 year after approximate due date of baby
Primary Difference in rates of continuum of care utilization between treatment and control groups The research team will use mother's interactions with other local service agencies involved in the locality's continuum of care system to quantify the impact of receiving a bed in the maternity home on continuum of care interactions. 1 year after approximate due date of baby
Primary Difference in employment rates between treatment and control groups The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported employment. 1 year after approximate due date of baby
Primary Difference in safety-net utilization rates between treatment and control groups The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported amount of welfare received, for example TANF, WIC, SNAP, etc. 1 year after approximate due date of baby
Primary Difference in education rates between treatment and control groups The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported education level. 1 year after approximate due date of baby
Secondary Difference in housing stability between treatment and control groups The research team will explore using information from Infutor Data Solutions to also capture address changes and will compare these findings with the self-reported information about housing. Infutor data will only be an exploratory outcome. 1 year after approximate due date of baby
See also
  Status Clinical Trial Phase
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Completed NCT03284515 - Vaccination In Pregnancy Gene Signature: VIP Signature Study
Recruiting NCT05969795 - Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support Phase 1
Recruiting NCT06051201 - Innovation for Small-scale Experiments: ReceptIVFity Test N/A
Recruiting NCT04828382 - Prospective Study of Pregnancy in Women With Cystic Fibrosis
Enrolling by invitation NCT04527926 - STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy N/A
Recruiting NCT04278651 - Early Antenatal Support for Iron Deficiency Anemia Phase 4
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting NCT06258902 - Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Completed NCT05487196 - Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia Phase 2
Completed NCT03750968 - Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects Phase 2
Enrolling by invitation NCT06127277 - Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care N/A
Completed NCT05897697 - Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Completed NCT04296396 - Opioid Prescription After Cesarean Trial Phase 3
Not yet recruiting NCT06069856 - Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06069869 - Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06079918 - Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania Phase 3
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A